| Serial Number | 79346494 |
| Word Mark | CDEMO |
| Filing Date | Tuesday, May 17, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 7, 2023 |
| Registration Number | 7209551 |
| Registration Date | Tuesday, November 7, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 22, 2023 |
| Goods and Services | Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials, namely, processing of biopharmaceutical materials; processing of pharmaceutical preparations; custom manufacture of pharmaceuticals; preservation of pharmaceuticals; processing of medical products, namely, chemical processing of pharmaceuticals; processing of chemicals; chemical treatment of liquid pharmaceutical preparations; chemical processing of medicinal materials |
| Goods and Services | Biosimilar pharmaceuticals for the treatment of cancer and prevention of viruses; human immune globulin for the treatment of cancer and prevention of viruses; antibodies for medical purposes for treatment of viral and infectious diseases; pharmaceutical preparations, namely, immunomodulators for the treatment of cancer and prevention of viruses; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceuticals for the treatment of cancer and prevention of viruses; pharmaceutical compositions for the treatment of cancer and prevention of viruses; pharmaceutical biosimilars for human use for the treatment of cancer and prevention of viruses; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; biosimilar pharmaceuticals for the treatment of cancer; human vaccine preparations; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; viral vaccines; pharmaceutical products for the treatment of viral diseases; anti-viral agents |
| Goods and Services | Biological preparations, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; reagents for scientific or medical research use; cell growth media for growing cells for use in scientific research; biochemical preparations, namely, monoclonal antibodies for scientific purposes; markers being biological preparations for analyzing proteins for scientific or laboratory purposes; reagents for analyzing proteins for scientific or laboratory purposes; protein preparations for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes; nucleic acid preparations for scientific or laboratory purposes; buffer solutions for scientific purposes; cultures of microorganisms for scientific or laboratory purposes; cells for scientific or laboratory purposes; cultures of microorganisms for character change for scientific or laboratory purposes |
| Goods and Services | Development of biologics; design of biologics; research of biologics; research and development services in the field of engineering; providing advice in the field of technological research relating to pharmaceutical manufacturing process technology; scientific and technological services, namely, scientific research, medical and scientific research, pharmaceutical screening for scientific research purposes, biological research; development of industrial processes; industrial process research in the field of pharmaceuticals and biological research; research relating to the computerised automation of technical processes; research relating to the computerised automation of industrial processes; quality control for others; process monitoring for quality assurance in the field of pharmaceuticals; research and development of devices for chemical processing; research and development of pilot equipment for chemical processing; consultancy in the field of engineering; providing consultation, advice, and information in the field of engineering research; product research and development in the fields of products for the treatment of viral and infectious diseases, products for the treatment of cancer, viral vaccines, pharmaceutical products for the treatment of viral diseases, and anti-viral agents |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 5, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 5, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 5, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 17, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Prestige Biologics Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | KR |
| Party Name | Prestige Biologics Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | KR |
| Party Name | Prestige Biologics Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | KR |
| Event Date | Event Description |
| Monday, March 4, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, February 8, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, February 8, 2024 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 7, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 7, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 7, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 22, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 22, 2023 | PUBLISHED FOR OPPOSITION |
| Monday, August 21, 2023 | NOTIFICATION PROCESSED BY IB |
| Wednesday, August 2, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 2, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 2, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, July 17, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, July 17, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, July 17, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, July 17, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, July 17, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 24, 2023 | REFUSAL PROCESSED BY IB |
| Wednesday, May 3, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, May 2, 2023 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 14, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, March 13, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 7, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, August 9, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 5, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 4, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |